Back
Zentalis Pharmaceuticals, Inc. 10K Form
Sell
18
ZNTL
Zentalis Pharmaceuticals, Inc.
Last Price:
$1.40
Seasonality Move:
-19.35%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive ZNTL News And Ratings
See the #1 stock for the next 7 days that we like better than ZNTL
ZNTL Financial Statistics
Sales & Book Value
| Annual Sales: | $67.4M |
|---|---|
| Cash Flow: | $-27M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $3.50 |
| Price / Book: | 0.4 |
Profitability
| EPS (TTM): | -2.08330 |
|---|---|
| Net Income (TTM): | $-149.3M |
| Gross Margin: | $66.1M |
| Return on Equity: | -49.3% |
| Return on Assets: | -38.41% |
Zentalis Pharmaceuticals, Inc. Earnings Forecast
Key Zentalis Pharmaceuticals, Inc. Financial Ratios
-
The Gross Profit Margin over the past 7 years for ZNTL is 98.09%.
-
The Selling, General & Administrative Expenses for ZNTL have been equal to 129.20% of Gross Profit Margin.
-
The Research & Development expenses have been 248.82% of Revenue.
-
The Net Earning history of ZNTL is -246.00% of Total Revenues.
-
Per Share Earnings over the last 7 years have been positive in 2 years.
Zentalis Pharmaceuticals, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | ZNTL |
| CUSIP: | 98943L |
| Website: | zentalis.com |
Debt
| Debt-to-Equity Ratio: | 0.16 |
|---|---|
| Current Ratio: | 7.76 |
| Quick Ratio: | 7.55 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
ZNTL Technical Analysis vs Fundamental Analysis
Sell
18
Zentalis Pharmaceuticals, Inc. (ZNTL)
is a Sell
Is Zentalis Pharmaceuticals, Inc. a Buy or a Sell?
-
Zentalis Pharmaceuticals, Inc. stock is rated a SellThe current Zentalis Pharmaceuticals, Inc. [ZNTL] share price is $1.39. The Score for ZNTL is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.